ALIOF Stock UPDATES Actelion Ltd (ALIOF) 123.0500 08/26/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Actelion Ltd (ALIOF) 123.0500 $ALIOF

Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 4:10PM CDT
Ligand Pharmaceuticals Incorporated (LGND) entered into a deal with Avion Pharmaceuticals, LLC, under which four Captisol-enabled programs will be developed and commercialized.

Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 3:45PM CDT
Achillion Pharmaceuticals (ACHN) reported positive interim results from a phase II study on ACH-3102.

Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 12:34PM CDT
Gilead (GILD) received a favorable verdict on Sovaldi.

TrovaGene (TROV) Worth Watching: Stock Rises 8.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 8:39AM CDT
TrovaGene, Inc. (TROV) was a big mover last session, as its shares rose almost 9% on the day.

NewLink Genetics Corp. (NLNK) Jumps: Stock Adds 8.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 7:51AM CDT
NewLink Genetics Corporation (NLNK) was a big mover last session, as its shares rose almost 9% on the day.

Achillion Pharmaceuticals (ACHN) in Focus: Stock Up 9.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 7:44AM CDT
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares gain nearly 10% on the day.

Epizyme (EPZM) Crumbles: Stock Falls by 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Aug 18, 7:33AM CDT
Epizyme has been witnessing a flat movement in its earnings estimate front and its share price has been declining for past 24 hours

Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 4:20PM CDT
Amgen (AMGN) suffered a major setback when its phase III study, FOCUS on multiple myeloma treatment, Kyprolis did not meet its primary endpoint.

Genomic Health Raised to Buy on Better-than-Expected Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 11:10AM CDT
Genomic Health's (GHDX) sales grossed $70.5 million, up 10.7% year over year, exceeding the Zacks Consensus Estimate of $69 million

Halozyme Gains on Narrower-than-Expected Loss, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 9:53AM CDT
The company's second quarter 2014 loss came in at 13 cents per share, narrower than the year-ago loss of 20 cents per share and the Zacks Consensus Estimate of a loss of 18 cents per share.

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 8:39AM CDT
Insmed Incorporated (INSM) was a big mover last session, as its shares rose nearly 11% on the day.

InterMune (ITMN) Jumps: Stock Adds 14.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 14, 7:51AM CDT
InterMune, Inc. (ITMN) was a big mover last session, as its shares rose over 14% on the day.

Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 1:37PM CDT
Shares of Dendreon Corporation (DNDN) were down significantly after the company warned that it will not be able to repay or refinance its notes due 2016.

BioDelivery Sciences Q2 Loss Narrows, Up on Solid Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 12:02PM CDT
Shares of BioDelivery Sciences International, Inc. (BDSI) jumped 7.58 % after the company reported its second-quarter 2014 results.

Myriad Genetics' Q4 Earnings Beat Estimates, Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 8:40AM CDT
In the fourth quarter, Myriad Genetics' (MYGN) total revenue climbed 8.4% year over year to $188.8 million, beating the Zacks Consensus Estimate of $187 million by a whisker.

Intercept Pharmaceuticals (ICPT) Worth Watching: Stock Gains 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 8:25AM CDT
Intercept Pharmaceuticals (ICPT) was a big mover last session, with shares rising nearly 17% on the day.

Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 4:20PM CDT
Regeneron's (REGN) Eylea has been approved for a third indication in the EU.

Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 1:49PM CDT
Sarepta reported second quarter loss of 85 cents per share compared to a loss of 60 cents per share in the year-ago quarter.

MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 10:05AM CDT
MannKind's (MNKD) loss of 19 cents per share was wider than the Zacks Consensus Estimate of a loss of 11 cents

OvaScience (OVAS) Shows Strength: Stock Up 7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 12, 8:39AM CDT
OvaScience, Inc. (OVAS) was a big mover last session, as its shares rose roughly 7% on the day.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Next Bridge Hydrocarbons' Call for Presidential Intervention

Updated Category News Views 48

Trump's New Team: A Hope for Shareholder Relief? Picture the scene—Next Bridge Hydrocarbons, caught in the depths of shareholder unrest over the unresolved MMTLP fiasco, is looking to the top for answers. With a fresh face, Stephen Miller, stepping in as the White House Chief of Staff, there's a new angle at play. They're knocking on the doors of the Trump...

Continue Reading
New Leadership at Reactive Tech: Claudio Facchin Steps In

Updated Category News Views 154

Facchin Joins Reactive Technologies: Power Play or Predictable Move? Let me tell you, the energy sector ain’t for the faint-hearted—especially when you’re talking grid stability. Reactive Technologies just tossed an ace on the table, appointing Claudio Facchin as the new Board Chairman. If you've been around the block, you might recognize Facchin's name from his...

Continue Reading
Innovative Eyewear Powers Ahead with 51% Revenue Boost

Updated Category News Views 64

Big Gains and Bigger Moves Ahead Here's a bit of sunshine for your investment portfolio: Innovative Eyewear's third-quarter results are packing quite the punch, showing a strong 51% uptick in revenue year-over-year. If you've got a stake in NASDAQ:LUCY, pay close attention. This ain't just a flash in the pan; it's a consistent rise, marking their 13th consecutive quarter...

Continue Reading
Why Retaining Wall Drainage Can’t Be an Afterthought

Updated Category News Views 47

The overlooked hero in wall longevity People might think building a retaining wall is just stacking stones or pouring concrete, but that's only part of the story. According to Justin Hundich, our go-to guy on landscape and drainage matters, there's way more at play than meets the eye. If you ignore drainage, you're steaming toward disaster, my friend—no two ways about...

Continue Reading
Outer Spaces Unveils OS1 at Major Energy Expo

Updated Category News Views 105

Introduction to the Future of Solar Living Just when you thought you'd seen it all, along comes Outer Spaces with their OS1—a solar pavilion and battery deck that looks at residential energy with fresh eyes. Debuting at the RE+ 2026 in Las Vegas, this isn't just another gizmo. This is about bringing solar power to your backyard without making your roof look like it...

Continue Reading
OpenHear BM420: CES 2027 Honoree for Accessibility

Updated Category News Views 58

Shokz's Big Leap With OpenHear BM420 Alright, this recognition for Shokz comes out of the left field for anyone not keeping an eye on their trajectory lately. From headphones to hearing aids—Shokz takes a genuine shot at making life easier for folks struggling with hearing issues. The CES 2027 Innovation Award for their OpenHear BM420 shows the tech's real potential in...

Continue Reading
Illinois Ban Risks Boosting Illicit THC Drink Sales

Updated Category News Views 61

Illinois Cranks Up the Heat on Low-Dose THC Drinks Illinois, you've really done it this time. When it comes to low-dose THC beverages, the state is setting up shop for illicit sellers by going harsher than federal standards. On November 12, these drinks, which have a loyal following, will be off the shelves—thanks to a reclassification that lumps them in with more...

Continue Reading
Krispy Kreme Faces Legal Heat Post McDonald's Exit

Updated Category News Views 48

Krispy Kreme's Sugar-Coated Trouble Ah, Krispy Kreme, where donuts and legal woes seem to go hand in hand these days. Dropping donuts might be a morning mishap, but dropping a stock by 37%? Now that’s a disaster, especially when folks like Schubert Jonckheer & Kolbe smell a rat in the kitchen. Fresh Out of the Baker's Oven: Lawsuit Updates On August 26, 2026, a...

Continue Reading
Rainmaker's Cloud Seeding Milestone: Big Leap or Hype?

Updated Category News Views 34

Pioneering Cloud Seeding: Rainmaker's Big Talk Mornings like this, I find myself wondering if we're still all buying snake oil—or if the future just landed in our laps. Rainmaker Technology Corporation just dropped what might be a game-changer or a grand illusion for those of us with a finger on the pulse of water tech. Their study in 'Atmosphere' paints a picture of...

Continue Reading
ALP's Bold NYC Pop-Up: A Gamble or Genius Move?

Updated Category News Views 20

ALP Swings Big in the Big Apple Here's a move that's about as loud as blaring your TV at midnight — ALP, the nicotine pouch brand that’s been taking quiet corners of rural America by storm, is barging into New York City with a brazen pop-up and a parade of marketing antics. Think of it as taking the Wild West and plunking it down in the urban jungle. They're...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Strategies: Invivyd's Future in Biopharmaceuticals

Updated Category News Views 106

Invivyd's Upcoming Financial Results Conference Call Invivyd, Inc. (Nasdaq: IVVD), a pioneering leader in the biopharmaceutical industry, has exciting developments lined up for their investors. On an upcoming Thursday morning, the company will host a conference call aimed at discussing their financial performance and business strategies. This communication will take place...

Continue Reading
How Young Chinese Artists Merge Tradition with Trendy Culture

Updated Category News Views 194

The emergence of young Chinese artists reshaped the cultural scene by fusing traditional elements with contemporary expressions. This isn’t just a passing phase; it’s a full-blown movement where the youth aren’t merely adopting global trends but redefining them with their unique insights. Take Liu Qingyi, for example. The 19-year-old breakdancer dazzled audiences at...

Continue Reading
STRATA Skin Sciences Announces Participation in Global Conference

Updated Category News Views 106

STRATA Skin Sciences to Attend D. Boral Capital Conference STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a prominent medical technology company, is set to participate in the D. Boral Capital Inaugural Global Conference. This significant event will be held in a leading location, offering the perfect platform for STRATA to showcase its...

Continue Reading
Medecision and Sendero Health Plans Unite to Transform Care

Updated Category News Views 190

Medecision Partners with Sendero Health Plans for Health Improvement Medecision, a leader in clinical data solutions, has announced an exciting partnership with Sendero Health Plans, a nonprofit healthcare organization. Together, they aim to significantly enhance health outcomes within the communities of Central Texas. Commitment to Quality Care Sendero Health Plans is...

Continue Reading
Julia Vorholt Honored with Prestigious Biotechnology Award

Updated Category News Views 182

Julia Vorholt's Groundbreaking Research Professor Julia Vorholt has made significant contributions to our understanding of plant health through her pioneering research on plant microbiomes. Her work reveals that just like humans rely on beneficial gut bacteria, plants too harbor communities of microorganisms that play a vital role in their development. This revelation...

Continue Reading